Invasive Cervical Cancer

Clinical Gynecologic Oncology

Volumn , Issue , 2007, Pages 55-124

  Monk, Bradley J ^a   Tewari, Krishnansu S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882460848     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-032303978-9.50006-X     Document Type: Chapter

References (437)

1. Andersen BL, Lachenbruch PA, Andersen B, et al. Sexual dysfunction and signs of gynecologic cancer. Cancer 1986, 57:1880.
2. Boon ME, de Graaff Guilloud JC, Kok LP, et al. Efficacy of screening for cervical squamous and adenocarcinoma: The Dutch experience. Cancer 1987, 59:862.
3. Coppleson M, Reid B. The etiology of squamous carcinoma of the cervix (Editorial). Obstet Gynecol 1968, 32:432.
4. Hildesheim A, Brinton LA, Mallin K, et al. Barrier and spermicidal contraceptive methods and risk of invasive cervical cancer (see comments). Epidemiology 1990, 1:266.
5. Pagliusi SR, Aguado MT Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine 2004, 23:569.
6. Piper JM Oral contraceptives and cervical cancer. Gynecol Oncol 1985, 22:1.
7. Seibel MM, Freeman MG, Graves WL Carcinoma of the cervix and sexual function. Obstet Gynecol 1980, 55:484.
8. World Health Organization Classification of Tumors: Pathology and Genetics of Tumours of the Breast and Female Genital Organs 2003, IARC Press, Lyon, section 1. F.A. Tavassoli, P. Devilee (Eds.).
9. Weijmar Schultz WCM, Van De Wiel HBM, Bouma J. Psychosexual functioning after treatment for cancer of the cervix: A comparative and longitudinal study. Int J Gynecol Cancer 1991, 1:37.
10. West RR Cervical Cancer: Age at registration and age at death. Br J Cancer 1977, 35:236.
11. Argenta PA, Kubicek GJ, Dusenberry KE, Judson PL, Downs LS, Carson LF, Boente MP Widespread lymph node metastases in young women with FIGO stage IA1 squamous cervical cancer. Gynecol Oncol 2005, 97:659.
12. Benedet JL, Anderson GH, Boyes DA Colposcopic accuracy in the diagnosis of microinvasive and occult invasive carcinoma of the cervix. Obstet Gynecol 1985, 65:557.
13. Boutselis JG, Ullery JC, Charmer L. Diagnosis and management of stage Ia (microinvasive) carcinoma of the cervix. Am J Obstet Gynecol 1971, 110:984.
14. Boyce DA, Worth AJ Treatment of early cervical neoplasia: Definition and management of preclinical invasive carcinoma. Gynecol Oncol 1981, 12:317.
15. Boyce DA, Worth AJ, Fidler HK The results of treatment of 4389 cases of preclinical cervical squamous carcinoma. J Obstet Gynaecol Br Commonw 1970, 77:769.
16. Burghardt E, Girardi F, Lahousen M, et al. Microinvasive carcinoma of the uterine cervix. Cancer 1991, 67:1037.
17. Copeland LJ, Silva EE, Gershenson DM, Morris M, et al. Superficially invasive squamous cell carcinoma of the cervix. Gynecol Oncol 1992, 45:307.
18. Creasman WT, Fetter BF, Clarke-Pearson DL, et al. Management of stage Ia carcinoma of the cervix. Am J Obstet Gynecol 1985, 153:164.
19. Creasman WT, Parker RT Microinvasive carcinoma of the cervix. Clin Obstet Gynecol 1973, 16:261.
20. Creasman WT, Zano RJ, Major FJ, et al. Early invasive carcinoma of the cervix (3-5 mm invasion): Risk factors and prognosis. Am J Obstet Gynecol 1998, 178:62.
21. Girardi F, Burghardt E, Pickel H. Small stage Ib cervical cancer. Gynecol Oncol 1994, 55:427.
22. Gurgel M, Bedone AJ, Androde L, et al. Microinvasive carcinoma of the uterine cervix: Histological findings on cone specimens related to residual neoplasia on hysterectomy. Gynecol Oncol 1997, 65:437.
23. Halzer E Microinvasive carcinoma of the cervix: clinical aspects, treatment, and follow-up. Minimal Invasive Cancer 1982, 315. WB Saunders, Philadelphia. E. Burghardt, E. Halzer (Eds.).
24. Hasumi K, Sakamoto A, Sugano H. Microinvasive carcinoma of the uterine cervix. Cancer 1980, 45:928.
25. Hopkins MP, Morley GW Squamous cell cancer of the cervix: Prognostic factors related to survival. Int J Gynecol Cancer 1991, 1:173.
26. Hopkins MP, Morley GW Squamous cell carcinoma of the cervix: Clinical pathological features related to survival. Am J Obstet Gynecol 1991, 164:1520.
27. Kolstad P Follow-up study of 232 patients with stage Ia1 and 411 patients with stage Ia2 squamous cell carcinoma of the cervix (microinvasive carcinoma). Gynecol Oncol 1989, 33:265.
28. Leman MH, Benson WL, Kurman RJ, et al. Microinvasive carcinoma of the cervix. Obstet Gynecol 1976, 48:571.
29. Lohe KJ Early squamous cell carcinoma of the uterine cervix I. Gynecol Oncol 1978, 6:10.
30. Lohe KJ Early squamous cell carcinoma of the uterine cervix III. Gynecol Oncol 1978, 6:51.
31. Lohe KJ, et al. Early squamous cell carcinoma of the uterine cervix II. Gynecol Oncol 1979, 6:31.
32. Maiman MA Superficially invasive squamous cell carcinoma of the cervix. Obstet Gynecol 1988, 72(3 pt 1):399.
33. Mestwerdt G About the micro-carcinoma of the uterine cervix, colposcopy, cytology, histology and treatment. An Bras Ginecol 1965, 59:181-201.
34. Morice P, Piovesan P, Rey A, et al. Prognostic value of lymphovascular space invasion determined with hematoxylin-eosin staining in early stage cervical carcinoma: Results of a multivariate analysis. Ann Oncol 2003, 14:1511.
35. Östör AG, Rome RM Microinvasive squamous cell carcinoma of the cervix: A clinicopathologic-pathologic study of 200 cases with long-term follow-up. Int J Gynecol Cancer 1994, 4:257.
36. Roche WD, Norris HJ Microinvasive carcinoma of the cervix: The significance of lymphatic invasion and confluent patterns of stromal growth. Cancer 1985, 180:180.
37. Sedlis A, Gall S, Tsukoda Y, et al. Microinvasive carcinoma of the uterine cervix: A clinical pathologic study. Am J Obstet Gynecol 1979, 133:67.
38. Seski JC, Abell MR, Morley GW Microinvasive squamous carcinoma of the cervix. Obstet Gynecol 1977, 50:410.
39. Sevin BU, Nadji M, Averette HE, et al. Microinvasive carcinoma of the cervix. Cancer 1992, 70:2121.
40. Simon NL, Gore H, Shingleton HM Study of superficially invasive carcinoma of the cervix. Obstet Gynecol 1986, 68:19.
41. Takeshima N, Yanoh K, Tabatat, et al. Assessment of the revised International Federation of Gynecology and Obstetrics staging for early invasive squamous cervical cancer. Gynecol Oncol 1999, 74:165.
42. Tsukamoto N, Kaku T, Matsukuma K, et al. The problem of stage Ia (FIGO 1985) carcinoma of the uterine cervix. Gynecol Oncol 1989, 34:1.
43. Van Nagell, Greenwell N, Powell DF, et al. Microinvasive carcinoma of the cervix. Am J Obstet Gynecol 1983, 145:982.
44. Yasgashi N, Sata S, Inque Y, et al. Comparative surgical treatment in cervical cancer with 3-5 mm stromal invasion in the absence of confluent invasion and lymph-vascular pace involvement. Gynecol Oncol 1994, 54:333.
45. Acs J, Hildesheim A, Reeves WC, et al. Regional distribution of human papillomavirus DNA and other risk factors for invasive cervical cancer in Panama. Cancer Res 1989, 49:5725.
46. Barron BA, Richart RM A statistical model of the natural history of cervical carcinoma based on a prospective study of 557 cases. J Natl Cancer Inst 1968, 41:1343.
47. Berman ML, Keys H, Creasman W, et al. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes. Gynecol Oncol 1984, 19:8.
48. Brinton LA Epidemiology of cervical cancer-overview. IARC 1993, 3.
49. Brinton LA Oral contraceptives and cervical neoplasia. Contraception 1991, 43:58l.
50. Burger MP, Hollema M, Gouw AS, et al. Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality. Br Med J 1993, 306:749.
51. Chu J, White E. Decreasing incidence of invasive cervical cancer in young women. Am J Obstet Gynecol 1987, 157:1105.
52. Daling JR, Sherman KJ, Hislop TG, et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 1992, 135:180.
53. Delgado G, Bundy BN, Fowler WC, et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 1989, 35:314.
54. Gagnon F The lack of occurrence of cervical carcinoma in nuns. Proc Second Natl Cancer Conf 1952, 1:625.
55. Henriksen E The dispersion of cancer of the cervix. Radiology 1950, 54:812.
56. Henriksen E Distribution of metastases in stage I carcinoma of the cervix. Am J Obstet Gynecol 1960, 80:919.
57. Henriksen E The lymphatic spread of carcinoma of the cervix and of the body of the uterus: A study of 420 necropsies. Am J Obstet Gynecol 1949, 58:924.
58. Hopkins MP, Morlay GW Squamous cell carcinoma of the cervix: Clinical pathological features related to survival. Am J Obstet Gynecol 1991, 164:1520.
59. Mvula M, Iwasaka T, Matsuo N, et al. Detection of human papillomavirus types 16 and 18 in primary and metastatic lesions of cervical carcinomas. Gynecol Oncol 1994, 53:156.
60. Reeves WC, Brinton LA, Garcia M, et al. Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med 1989, 320:1437.
61. Simons AM, Philips DH, Coleman DV Damage to DNA in cervical epithelium related to smoking tobacco. Br Med J 1993, 306:1444.
62. Slattery ML, Robison LM, Schuman KL, et al. Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. JAMA 1989, 261:1593.
63. Ursin G, Peters RK, Henderson BE, et al. Oral contraceptive use and adenocarcinoma of cervix. Lancet 1994, 344:1390.
64. Angel C, Dubeshter B, Lin JY Clinical presentation and management of stage I cerical adenocarcinoma: A 25-year experience. Gynecol Oncol 1992, 44:71.
65. Anton-Culver H, Bloss JD, Bringman D, et al. Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: A population based epidemiologic study. Am J Obstet Gynecol 1992, 166:1507.
66. Berek JS, Castaldo TW, Hacker NF, et al. Adenocarcinoma of the uterine cervix. Cancer 1981, 48:2734.
67. Boon ME, Baak JP, Kurver PJ, et al. Adenocarcinoma in situ of the cervix. Cancer 1981, 48:768.
68. Brand E, Berek JS, Hacker NF Controversies in the management of cervical adenocarcinoma. Obstet Gynecol 1988, 71:261.
69. Chen RW, Change DY, Yen ML, et al. Prognostic factors of primary adenocarcinoma of the uterine cervix. Gynecol Oncol 1998, 69:157.
70. Davidson SE, Symonds RP, Lamont D, et al. Does adenocarcinoma of uterine cervix have a worse prognosis than squamous carcinoma when treated by radiotherapy?. Gynecol Oncol 1989, 33:23.
71. Duk JM, Aalders JG, Fleuren GJ, et al. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix. Obstet Gynecol 1989, 73:661.
72. Eifel PJ, Burke TW, Delclos L, et al. Early stage I adenocarcinoma of the uterine cervix: Treatment results in patients with tumors 4 cm in diameter. Obstet Gynecol 1991, 41:199.
73. Eifel PJ, Burke TW, Morris M, et al. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol 1995, 59:38.
74. Eifel PJ, Morris M, Oswald MJ, et al. Adenocarcinoma of the uterine cervix. Cancer 1990, 65:2507.
75. Eifel PJ, Burke TW, Delclos L, et al. Early stage I adenocarcinoma of the uterine cervix: Treatment results in patients with tumors 4 cm in diameter. Gynecol Oncol 1991, 41:199.
76. El-Ghobashy AA, Shaaban AM, Herod J, Herrington CS The pathology and management of endocervical glandular neoplasia. Int J Gynecol Cancer 2005, 15:583.
77. Hopkins MP, Morlay GW Comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 1991, 77:912.
78. Hopkins MP, et al. The prognosis and treatment of stage I adenocarcinoma of the cervix. Obstet Gynecol 1988, 72:915.
79. Kaku T, Kamura T, Sakai K, et al. Early adenocarcinoma of the uterine cervix. Gynecol Oncol 1997, 65:281-285.
80. Kilgore LC, Soong SJ, Gore H, et al. Analysis of prognostic features in adenocarcinoma of the cervix. Gynecol Oncol 1988, 31:137.
81. Kjorstad KE, Bond B. Stage Ib adenocarcinoma of the cervix: Metastatic potential and patterns of dissemination. Am J Obstet Gynecol 1984, 150:297.
82. Kleine W, Rau K, Schwoeorer D, et al. Prognosis of the adenocarcinoma of the cervix uteri: A comparative study. Gynecol Oncol 1989, 35:145.
83. Lai CH, Hsueh S, Hong JH, et al. Are adenocarcinomas and adenosquamous carcinomas different from squamous carcinomas in stages IB and II cervical cancer patients undergoing primary surgery?. Int J Gynecol Cancer 1999, 9:28.
84. Matthews CM, Burke TW, Tomos C, et al. Stage I cervical adenocarcinoma: Prognostic evaluation of surgically treated patients. Gynecol Oncol 1993, 49:19.
85. McHale MT, Le TD, Burger RA, Gu M, Rutgers JL, Monk BJ Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix. Obstet Gynecol 2001, 98:726.
86. Moberg PJ, Einborn N, Silfversward C, et al. Adenocarcinoma of the uterine cervix. Cancer 1986, 57:407.
87. Östör A, Rome R, Quinn M. Microinvasive adenocarcinoma of the cervix: A clinicopathologic study of 77 women. Obstet Gynecol 1997, 89:88.
88. Parazzin IF, LaVecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1990, 39:4.
89. Prempree T, Amornmarn R, Wizenberg MJ A therapeutic approach to primary adenocarcinoma of the cervix. Cancer 1985, 56:1264.
90. Raju KS, Kjorstad KE, Abeler V. Prognostic factors in the treatment of stage 1b adenocarcinoma of the cervix. Int J Gynecol Cancer 1991, 1:69.
91. Rose PG, Reale FR Case Report: Serous papillary carcinoma of the cervix. Gynecol Oncol 1993, 50:361.
92. Rutledge FN, Gutierrez AG, Fletcher GH Management of stage I and II adenocarcinomas of the uterine cervix on intact uterus. AJR Am J Roentgenol 1968, 102:161.
93. Schorge JO, Lee KR, Flynn CE, et al. Stage IA1 cervical adenocarcinoma: Definition and treatment. Obstet Gynecol 1997, 89:88.
94. Yamakawa Y, Forslund O, Teshima H, et al. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR). Gynecol Oncol 1994, 53:190.
95. Young RH, Scully RE Invasive adenocarcinoma and related tumors of the urterine cervix. Semin Diagn Pathol 1990, 7:205.
96. Abeler VM, Holm R, Nesland JM, Kjorstad KE Small cell carcinoma of the cervix. Cancer 1994, 73:672.
97. Barrett RJ, Davos I, Leuchter RS, et al. Neuroendocrine features in poorly differentiated and undifferentiated carcinomas of the cervix. Cancer 1987, 60:1089.
98. Chan JK, Loizzi V, Burger RA, Rutgers J, Monk BJ Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer 2003, 97:568.
99. Hoskins PJ, et al. Small cell carcinoma of the cervix treated with concurrent radiotherapy, cisplatin, and etoposide. Gynecol Oncol 1995, 56:218.
100. Lewandowski GS, Copeland LJ Case report: A potential role for intensive chemotherapy in the treatment of small cell neuroendocrine tumors of the cervix. Gynecol Oncol 1993, 48:127.
101. Lotocki RJ, Krepart GV, Paraskevas M, et al. Glassy cell carcinoma of the cervix: A bimodal treatment strategy. Gynecol Oncol 1992, 44:254.
102. Morris M, Gershenson DM, Eifel P, et al. Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide. Gynecol Oncol 1992, 47:62.
103. Pazdur R, Bonomi P, Slayton R, et al. Neuroendocrine carcinoma of the cervix: Implications for staging and therapy. Gynecol Oncol 1981, 12:120.
104. Sheets EE, Berman ML, Hrountas CK, et al. Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet Gynecol 1988, 71:10.
105. Stoler MH, Mills SE, Gersell DJ, et al. Small-cell neuroendocrine carcinoma of the cervix. Am J Surg Pathol 1991, 15:28.
106. Tamimi HK, Ek M, Hesla J, et al. Glassy cell carcinoma of the cervix redefined. Obstet Gynecol 1988, 71:837.
107. Viswanathan AN, Deavers MT, Jhingran A, et al. Small cell neuroendocrine carcinoma of the cervix: Outcome and patterns of recurrence. Gynecol Oncol 2004, 93:27-33.
108. Belenson JL, Goldberg MI, Averette HE Para-aortic lymphadenectomy in gynecologic cancer. Gynecol Oncol 1979, 7:188.
109. Brenner DE, Whitley NO, Prempree T, et al. An evaluation of the computed tomographic scanner for the staging of carcinoma of the cervix. Cancer 1982, 50:2323.
110. Buchsbaum HJ Extrapelvic lymph node metastases in cervical carcinoma. Am J Obstet Gynecol 1979, 133:814.
111. Burke TW, Heller PB, Hoskins WJ, et al. Evaluation of the scalene lymph nodes in primary and recurrent cervical carcinoma. Gynecol Oncol 1987, 28:312.
112. Childers JM, Hatch K, Surwitt EA The role of laparoscopic lymphadenectomy in the management of cervical carcinoma. Gynecol Oncol 1992, 47:38.
113. Childers JM, Hatch K, Tran AN, Surwitt EA Laparoscopic para-aortic lymphadenectomy in gynecologic malignancies. Obstet Gynecol 1993, 82:741.
114. Dargent D Laparoscopic surgery and gynecologic cancer. Curr Opin Obstet Gynecol 1993, 5:294.
115. Delgato G, Smith JP, Ballantyne AJ Scalene node biopsy in carcinoma of the cervix; pelvic and para-aortic lymphadenectomy. Cancer 1975, 35:784.
116. Fuller AF, Elliott N, Kosloff C, et al. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIa carcinoma of the cervix. Gynecol Oncol 1998, 33:34.
117. Havrilesky LJ, Kulasingam SL, Matchar DB, Myers ER FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol 2005, 97:183.
118. Kupets R, Covens A. Is the International Federation of Gynecology and Obstetrics staging system for cervical carcinoma able to predict survival in patients with cervical carcinoma? An assessment of clinimetric properties. Cancer 2001, 92:796.
119. Lagasse LD, Creasman WT, Shingleton HM, et al. Results and complications of operative staging in cervical cancer: Experience of the Gynecologic Oncology Group. Gynecol Oncol 1980, 9:90.
120. Lanciano RM, Won M, Hanks GE A reappraisal of the international federation of gynecology and obstetrics staging system for cervical cancer. Cancer 1992, 69:482.
121. Memarzadeh S, Natarajan S, Dandade DP, et al. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer. Obstet Gynecol 2003, 102:612.
122. Nelson JH, Macasaet MA, Lu T, et al. The incidence and significance of para-aortic lymph node metastases in late invasive carcinoma of the cervix. Am J Obstet Gynecol 1974, 118:749.
123. Potish RA, Twiggs LB, Prem KA, et al. The impact of extra-peritoneal surgical staging on morbidity and tumor recurrence following radiotherapy for cervical carcinoma. Am J Clin Oncol 1984, 7:245.
124. Abbe R The use of radium in malignant disease. Lancet 1913, 2:524.
125. Alberts DS, Martimbeau PW, Surwit EA, et al. Mitomycin C, bleomycin, vincristine, and cis-platinum in the treatment of advanced recurrent squamous cell carcinoma of the cervix. Cancer Clin Trials 1981, 4:313.
126. Alberts DS, Garcia D, Mason-Liddil N. Cisplatin in advanced cancer of the cervix: An update. Semin Oncol 1991, 18:11.
127. Ampil F, Datta R, Datta S Elective postoperative external radiotherapy after hysterectomy in early-stage carcinoma of the cervix: Is additional vaginal cuff irradiation necessary?. Cancer 1987, 60:280.
128. Anderson B, LaPolla J, Turner D, et al. Ovarian transposition in cervical cancer. Gynecol Oncol 1993, 49:206.
129. Andras EJ, Fletcher GH, Rutledge F. Radiotheraphy of carcinoma of the cervix following simple hysterectomy. Am J Obstet Gynecol 1973, 115:647.
130. Artman LE, Hoskins WJ, Bibro MC, et al. Radical hysterectomy and pelvic lymphadenectomy for stage IB carcinoma of the cervix: 21 years' experience. Gynecol Oncol 1987, 28:8.
131. Bali A, Weekes A, van Trappen P, et al. Central pelvic recurrence 7 years after radical vaginal trachelectomy. Gynecol Oncol 2005, 96:854-856.
132. Bandy LC, Clarke-Pearson DL, Soper JT, et al. Long-term effects on bladder function following radical hysterectomy with and without postoperative radiation. Gynecol Oncol 1987, 26:160.
133. Barnes W, Waggoner S, Delgado G, et al. Manometric characterization of rectal dysfunction following radical hysterectomy. Gynecol Oncol 1991, 42:116.
134. Barton DPJ, Cavanagh D, Roberts WS, et al. Radical hysterectomy for treatment of cervical cancer: A prospective study of two methods of closed-suction drainage. Am J Obstet Gynecol 1992, 166:533.
135. Bernardini M, Barrett J, Seaward G, Covens A. Pregnancy outcomes in patients after radical trachelectomy. Am J Obstet Gynecol 2003, 189:1378-1382.
136. Bianchi UA, Sartori E, Pecorelli S, et al. Treatment of primary invasive cervical cancer; considerations on 997 consecutive cases. Eur J Gynaecol Oncol 1988, 9:47.
137. Bloss JD, Berman ML, Mukherejee J, et al. Bulky stage IB cervical carcinoma managed by primary radical hysterectomy followed by tailored radiotherapy. Gynecol Oncol 1992, 47:21.
138. Bonfiglio M The pathology of fracture of the femoral neck following irradiation. AJR Am J Roentgenol 1953, 70:449.
139. Bosch A, Marcial VA Carcinoma of the uterine cervix associated with pregnancy. AJR Am J Roentgenol 1966, 96:92.
140. Brack CB, Everett HC, Dickson R. Irradiation therapy for carcinoma of the cervix: Its effect on urinary tract. Obstet Gynecol 1956, 7:196.
141. Bremer GL, van der Putten HW, Dunselman GA, et al. Early stage cervical cancer: Aborted versus completed radical hysterectomy. Eur J Obstet Gynecol Reprod Biol 1992, 47:147.
142. Brenner DE, Gillette AW, Jones HW, et al. Simultaneous radiation and chemotherapy for advanced carcinoma of the cervix. Gynecol Oncol 1987, 26:381.
143. Brookland RK, Rubin S, Danoff BF Extended field irradiation in the treatment of patients with cervical carcinoma involving biopsy-proven para-aortic nodes. Radiat Oncol Biol Phys 1984, 10:1875.
144. Brown JV, Fu YS, Berek JS Ovarian metastases are rare in stage I adenocarcinoma of the cervix. Obstet Gynecol 1990, 76:623.
145. Burghardt E, Baltzer J, Tulusan AH, Haas J. Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer 1992, 70:648.
146. Carenza L, Nobili F, Giacobini S. Voiding disorders after radical hysterectomy. Gynecol Oncol 1982, 13:213.
147. Chambers SK, et al. Sequelae of lateral ovarian transposition in unirradiated cervical cancer patients. Gynecol Oncol 1990, 39:155.
148. Chapman JA, Mannel RS, DiSaia PJ, et al. Surgical treatment of unexpected invasive cervical cancer found at total hysterectomy. Obstet Gynecol 1992, 80:931.
149. Choo YC, Wong LC, Wong KP, et al. The management of intractable lymphocyst following radical hysterectomy. Gynecol Oncol 1986, 24:309.
150. Corn BW, et al. Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix. Gynecol Oncol 1994, 53:294.
151. Covens A, Shaw P, Murphy J, et al. Is radical trachelectomy a safe alternative to radical hysterectomy for patients with stage IA-B carcinoma of the cervix?. Cancer 1999, 86:2273-2279.
152. Creasman WT, Soper JT, Clarke-Pearson D. Radical hysterectomy as therapy for early carcinoma of the cervix. Am J Obstet Gynecol 1986, 155:964.
153. Currie DW Operative treatment of carcinoma of the cervix. J Obstet Gynaecol Br Commonw 1971, 78:385.
154. Czesnin K, Wronkowski Z. Second malignancies of the irradiated area in patients treated for uterine cervix cancer. Gynecol Oncol 1978, 6:309.
155. Dargent D, Enria R Laparoscopic assessment of the sentinel lymph nodes in early cervical cancer. Technique-preliminary results and future developments. Crit Rev Oncol/Hematol 2003, 48:305-310.
156. Delgato G, Caglar H, Walker P. Survival and complications in cervical cancer treated by pelvic and extended field radiation after para-aortic lymphadenectomy. AJR Am J Roentgenol 1978, 130:141.
157. Diakomanolis E, Haidopoulos D, Rodolakis A, et al. Laser CO2 conization. A safe mode of treating conservatively microinvasive carcinoma of the uterine cervix. Eur J Obstet Gynecol Reprod Biol 2004, 113:229-233.
158. DiSaia PJ, Bundy BN, Curry SL, et al. Phase III study on the treatment of women with cervical cancer, stage IIb, IIIb, and IVa (confined to the pelvis and/or periaortic nodes), with radiotherapy alone versus radiotherapy plus immunotherapy with intravenous Corynebacterium parvum: A Gynecologic Oncology Group study. Gynecol Oncol 1987, 26:386.
159. DiSaia PJ Surgical aspects of cervical carcinoma. Cancer 1981, 48:548.
160. DiSaia PJ The case against the surgical concept of en bloc dissection for malignancies of the reproductive tract. Cancer 1987, 60:2025.
161. Dottino PR, Plaxe SC, Beddoe AM, et al. Induction chemotherapy followed by radical surgery in cervical cancer. Gynecol Oncol 1991, 40:7.
162. Durance FY Radiotherapy following simple hysterectomy in patients with stage I and II carcinoma of the cervix. Am J Roentgenol Radium Ther Nucl Med 1968, 102:165-169.
163. Einstein MH, Kadish AS, Burk RD, et al. Heat shcok protein (HSP)-based immunotherapy (HspE7) for treatment of CIN III (NCI 5850, NYGOG). Gynecol Oncol 2005, 96:912a.
164. Falk V, Lungren N, Quarfordt L, et al. Primary surgical treatment of carcinoma stage I of the uterine cervix. Acta Obstet Gynecol Scand 1982, 61:481.
165. Feder BH, Syed AMN, Neblett D Treatment of extensive carcinoma of the cervix with the "transperineal parametrial butterfly.". Int J Radiat Oncol Biol Phys 1978, 4:735.
166. Fletcher GH, Rutledge FN Extended field technique in the management of the cancers of the uterine cervix. AJR Am J Roentgenol 1972, 114:116.
167. Forney JP The effect of radical hysterectomy on bladder physiology. Am J Obstet Gynecol 1980, 138:374.
168. Fotiou S, Tserkezoglou A, Hatzieleftheriou G, et al. Class III vs class II radical hysterectomy in stage IB cervical carcinoma: A comparison of morbidity and survival. Int J Gynecol Cancer 1997, 7:117.
169. Gallion HH, van Nagell JR, Donaldson ES, et al. Combined radiation therapy and extrafascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer. Cancer 1985, 56:262.
170. Garcia F, Petry KU, Muderspach L, et al. ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: A randomized controlled trial. Obstet Gynecol 2004, 103:317.
171. Giaroli A, Sananes C, Sardi JE, et al. Lymph node metastases in carcinoma of the cervix uteri: Response to neoadjuvant chemotherapy and its impact on survival. Gynecol Oncol 1990, 39:34.
172. Gilinsky WH, et al. The natural history of radiation-induced proctosigmoiditis: An analysis of 88 patients. Q J Med 1983, 205:40.
173. Gil-Moreno A, Diaz-Feijoo B, Roca I, et al. Total laparoscopic radical hysterectomy with intraoperative sentinel node identification in patients with early invasive cervical cancer. Gynecol Oncol 2005, 96:187-193.
174. Grosu AL, Piert M, Weber WA, et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 2005, 181:483.
175. Hatch KD, Parham G, Shingleton HM, et al. Ureteral strictures and fistulae following radical hysterectomy. Gynecol Oncol 1984, 19:17.
176. Heller PB, Barnhill DR, Mayer AR Cervical carcinoma found incidentally in a uterus removed for benign indications. Obstet Gynecol 1986, 67:187.
177. Herzog TJ New approaches for the management of cervical cancer. Gynecol Oncol 2003, 90:S22-S27.
178. Hopkins MP, Morley GW Radical hysterectomy versus radiation therapy for stage IB squamous cell cancer of the cervix. Cancer 1991, 68:272.
179. Hreschyshn MM, Aron BS, Boronow RC, et al. Hydroxyurea or placebo combined with radiation to treat stages IIIb and IV cervical cancer confined to the pelvis. Int J Radiat Oncol Biol Phys 1979, 5:317.
180. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004, 350:2335.
181. Husseinzadeh N, Van Aken ML, Aron B. Ovarian transposition in young patients with invasive cervical cancer receiving radiation therapy. Int J Gynaecol Cancer 1994, 4:61.
182. Inoue T, Morita K. 5-year results of postoperative extended-field irradiation on 76 patients with nodal metastases from cervical carcinoma stages Ib to IIIb. Cancer 1988, 61:2009.
183. Ito E, Saito T Nerve-preserving techniques for radical hysterectomy. Eur J Surg Oncol 2004, 30:1137-1140.
184. Jackson KS, Das N, Naik R, et al. Laparoscopically assisted radical vaginal hysterectomy vs. radical abdominal hysterectomy for cervical cancer: A matched controlled study. Gynecol Oncol 2004, 95:655-661.
185. Jakobsen A, Bichel P, Ahrons S, et al. Is radical hysterectomy always necessary in early cervical cancer?. Gynecol Oncol 1990, 39:80.
186. Jensen PT, Groenvold M, Klee MC, et al. Early-stage cervical carcinoma, radical hysterectomy, and sexual function: A longitudinal study. Cancer 2004, 100:97-106.
187. Johnston CM, Dottino PR, Heller DS, et al. Case report: Recurrent cervical squamous cell carcinoma in an ovary following ovarian conservation and radical hysterectomy. Gynecol Oncol 1991, 41:64.
188. Jolles CJ, Freedman RS, Hamberger AD, et al. Complications of extended-field therapy for cervical carcinoma without prior surgery. Radiat Oncol Biol Phys 1986, 12:179.
189. Kagan AR, Nussbaum H, Gilbert H, et al. A new staging system for irradiation injuries following treatment for cancer of the cervix uteri. Gynecol Oncol 1979, 7:166.
190. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky Stage IB cervical cancer. N Engl J Med 1999, 340:1154.
191. Khorram O, Stern JL Case report: Bleomycin sclerotherapy of an intractable inguinal lymphocyst. Gynecol Oncol 1993, 50:244.
192. Kim DS, Moon H, Hwang YY, et al. Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa, and IIb with bulky tumor. Gynecol Oncol 1988, 29:321.
193. Kim RY Radiotherapeutic management in carcinoma of the uterine cervix: current status. Int J Gynecol Cancer 1993, 3:337.
194. Kinney WK, Alvarez RD, Reid CC, et al. Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: A matched-control study. Gynecol Oncol 1989, 34:258.
195. Kinney WK, Egorshin EV, Ballard DJ, Podratz KC Long-term survival and sequelae after surgical management of invasive cervical carcinoma diagnosed at the time of simple hysterectomy. Gynecol Oncol 1992, 44:24.
196. Kirsten F, Atkinson KH, Coppleson JV, et al. Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer. Br J Obstet Gynaecol 1987, 94:583.
197. Kramer C, Peschel RE, Goldberg N, et al. Radiation treatment of FIGO stage IVa carcinoma of the cervix. Gynecol Oncol 1989, 32:323.
198. Krebs HB, Helmkamp BF, Sevin BU, et al. Recurrent cancer of the cervix following hysterectomy and pelvic node dissection. Obstet Gynecol 1982, 59:422.
199. Landoni F, Maneo A, Colombo A, et al. Randomized study of radical surgery versus radiotherapy for stage IB-IIA cervical cancer. Lancet 1997, 350:535.
200. Larson DM, Malone JM, Copeland LJ, et al. Ureteral assessment after radical hysterectomy. Obstet Gynecol 1987, 69:612.
201. Larson DM, Stringer CA, Copeland LJ, et al. Stage Ib cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy: Role of adjuvant radiotherapy. Obstet Gynecol 1987, 69:378.
202. Lee Y, Wang KL, Lin MH, et al. Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: A clinical review of 954 cases. Gynecol Oncol 1989, 32:135.
203. Lin L-Y, Wu J-H, Yang C-W, et al. Impact of radical hysterectomy for cervical cancer on urodynamic findings. Int Urogynecol J 2004, 15:418-421.
204. Lin YS, Tzeng CC, Huang KF, et al. Sentinel node detection with radiocolloid lymphatic mapping in early invasive cervical cancer. Int J Gynecol Cancer 2005, 15:273-277.
205. Liu W, Meigs JW Radical hysterectomy and pelvic lymphadenectomy. Am J Obstet Gynecol 1955, 69:1.
206. Maas CP, Trimbos JB, DeRuiter MC, et al. Nerve sparing radical hysterectomy: Latest developments and historical perspective. Crit Rev Oncol/Hematol 2003, 48:271-279.
207. Madhu J, et al. Preliminary results of concomitant radiotherapy and chemotherapy in advanced cervical carcinoma. Gynecol Oncol 1987, 28:101.
208. Mann WJ, Vogel F, Pastner B, et al. Management of lymphocysts after radical gynecologic surgery. Gynecol Oncol 1989, 33:248.
209. Mann WJ, Chumas J, Amalfitano T, et al. Ovarian metastases from stage Ib adenocarcinoma of the cervix. Cancer 1987, 60:1123.
210. Martinez-Palones JM, Gil-Moreno A, Perez-Benavente MA, et al. Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection. Gynecol Oncol 2004, 92:845-850.
211. 252Cf neutron brachytherapy for stage II cervical carcinoma. Gynecol Oncol 1991, 43:252.
212. Massi G, Savino L, Susini T. Schauta-Amreich vaginal hysterectomy and Wertheim-Meigs abdominal hysterectomy in the treatment of cervical cancer: A retrospective analysis. Am J Obstet Gynecol 1993, 168:928.
213. McCall ML A modern evaluation of the radical vaginal operation for carcinoma of the cervix. Am J Obstet Gynecol 1963, 85:295-301.
214. McIntyre JF, Eifel PJ, Levenback C, Oswald MJ Ureteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix. Cancer 1995, 75:837.
215. Miller BE, Copeland LJ, Hamberger AD, et al. Carcinoma of the cervical stump. Gynecol Oncol 1984, 18:100.
216. Mitra S Radical vaginal hysterectomy and extraperitoneal lymphadenectomy in cervical cancer. Zentralbl Gynakol 1951, 73:574-581.
217. Monk BJ, Cha DS, Walker JL, et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIa cervical carcinoma. Gynecol Oncol 1994, 54:4.
218. Monk BJ, Wang J, Im S, Stock RJ, Peters WA, Liu PY, Barrett RJ, Berek JS, Souhami L, Grigsby PW, Gordon W Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of the Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol 2005, 96:721.
219. Montana GS, Fowler WC, Varia MA, et al. Carcinoma of the cervix, stage III. Cancer 1986, 57:148.
220. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer. N Engl J Med 1999, 340:1137.
221. Morrow CP Is pelvic radiation beneficial in the postoperative management of stage Ib squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? 1980, 10:105.
222. Nam JH, Kim JH, Kim DY, et al. Comparative study of laparoscopico-vaginal radical hysterectomy and abdominal radical hysterectomy in patients with early cervical cancer. Gynecol Oncol 2004, 92:277-283.
223. Nolan JF, Anson JH, Steward M. A radium applicator for use in the treatment of cancer of the uterine cervix. AJR Am J Roentgenol 1958, 79:36.
224. Orr JW, Wilson K, Bodiford C. Corpus and cervix cancer: A nutritional comparison. Am J Obstet Gynecol 1985, 153:775.
225. Owens S, et al. Ovarian management at the time of radical hysterectomy for cancer of the cervix. Gynecol Oncol 1989, 35:349.
226. Panici PB, Greggi S, Scambia G, et al. High-dose cisplatin and bleomycin neoadjuvant chemotherapy plus radical surgery in locally advanced cervical carcinoma: A preliminary report. Gynecol Oncol 1991, 41:212.
227. Panici PB, Scambia G, Baiocchi G, et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer: Prognostic factors for response and survival. Cancer 1991, 67:372.
228. Park TK, Lee SK, Kim SN, et al. Combined chemotherapy and radiation for bulky stages I-II cervical cancer: Comparison of concurrent and sequential regimens. Gynecol Oncol 1993, 50:196.
229. Park TK, Choi DH, Kim SN, et al. Role of induction chemotherapy in invasive cervical cancer. Gynecol Oncol 1991, 41:1007.
230. Patsner B, Sedlacek TV, Lovecchio JL Para-aortic node sampling in small (3 cm or less) stage IB invasive cervical cancer. Gynecol Oncol 1992, 44:53.
231. Patsner B Closed-suction drainage versus no drainage following radical abdominal hysterectomy with pelvic lymphadenectomy for stage IB cervical cancer. Gynecol Oncol 1995, 57:232.
232. Perez CA, Breaux S, Madoc-Jones H, et al. Correlation between radiation dose and tumor recurrence and complications in carcinoma of the uterine cervix: stages I and IIa. Int J Radiat Oncol Biol Phys 1979, 5:373.
233. Perez CA, Breaux S, Askin F, et al. Irradiation alone or in combination with surgery in stages Ib and IIa carcinoma of the uterine cervix: A nonrandomized comparison. Cancer 1979, 43:1062.
234. Petersen LK, Mamsen A, Jakobsen A. Carcinoma of the cervical stump. Gynecol Oncol 1992, 46:199.
235. Photopulos GJ, Vander Zuang R, Miller B, et al. Vaginal radiation brachytherapy to reduce central recurrence after radical hysterectomy for cervical carcinoma. Gynecol Oncol 1990, 38:187.
236. Photopulos GJ, Van der Zwaag R Class II radical hysterectomy shows less morbidity and good treatment efficacy compared to class III. Gynecol Oncol 1991, 40:21.
237. Piver MS, Barlow JJ High dose irradiation to biopsy-confirmed aortic node metastases from carcinoma of the uterine cervix. Cancer 1977, 39:1243.
238. Piver MS, Rutledge FN, Smith PJ Five classes of extended hysterectomy of women with cervical cancer. Obstet Gynecol 1974, 44:265.
239. Piver MS Extended field irradiation in the treatment of patients with cervical carcinoma involving biopsy proven para-aortic nodes. Int J Radiat Oncol Biol Phys 1984, 10:1993.
240. Plante M, Renaud MC, Hoskins IA, Roy M Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature. Gynecol Oncol 2005, 98:3.
241. Pomel C, Atallah D, le Bouedec G, et al. Laparoscopic radical hysterectomy for invasive cervical cancer: 8-year experience of a pilot study. Gynecol Oncol 2003, 91:534-539.
242. Potish R, Adcock L, Jones TJ, et al. The morbidity and utility of periaortic radiotherapy in cervical carcinoma. Gynecol Oncol 1983, 15:1.
243. Puthawala A, Syed AM, Nalick R, et al. Integrated external and interstitial radiation therapy for primary carcinoma of the vagina. Obstet Gynecol 1983, 62:367.
244. Raspagliesi F, Ditto A, Fontanelli R, et al. Nerve-sparing radical hysterectomy: A surgical technique for preserving the autonomic hypogastric nerve. Gynecol Oncol 2004, 93:307-314.
245. Remy JC, DiMaio T, Fruchter RG, et al. Adjunctive radiation after radical hysterectomy in stage Ib squamous cell carcinoma of the cervix. Gynecol Oncol 1990, 38:161.
246. Rettenmaier MA, Casanova DM, Micha JP, et al. Radical hysterectomy and tailored postoperative radiation therapy in the management of bulky stage Ib cervical cancer. Cancer 1989, 63:2220.
247. Roman LD, Morris M, Mitchell MF, et al. Prognostic factors for patients undergoing simple hysterectomy in the presence of invasive cancer of the cervix. Gynecol Oncol 1993, 50:179.
248. Rose PG, Bundy BN, Watkins ED, et al. Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999, 340:1144.
249. Roy M, Plante M, Renaud M-C, Tetu B. Vaginal radical hysterectomy versus abdominal radical hysterectomy in the treatment of early-stage cervical cancer. Gynecol Oncol 1996, 62:336-339.
250. Rubin SC, et al. Para-aortic nodal metastases in early cervical carcinoma: Long-term survival following extended field radiotherapy. Gynecol Oncol 1984, 18:213.
251. Russell AH Comtemporary radiation treatment planning for patients with cancer of the uterine cervix. Semin Oncol 1994, 21:30.
252. Rutledge FN, Wharton JT, Fletcher GH Clinical studies with adjunctive surgery and irradiation therapy in the treatment of carcinoma of the cervix. Cancer 1976, 38:596.
253. Sakuragi N, Todo Y, Kudo M, et al. A systematic nerve-sparing radical hysterectomy technique in invasive cervical cancer for preserving postsurgical bladder function. Int J Gynecol Cancer 2005, 15:389-397.
254. Sandler AB, Gray R, Brahmer J et al: Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C) with or without bevacizumab (NSC # 704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): An Eastern Cooperative Oncology Group (ECOG) Trial-E499. ASCO 2005 Annual Meeting, Abstract #LBA4.
255. Sardi JE, di Paola GR, Cachau A, et al. A possible new trend in the management of the carcinoma of the cervix uteri. Gynecol Oncol 1986, 25:139.
256. Sardi JE, Giaroli A, Sananes C, et al. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage IB squamous carincoma of the cervix: The final results. Gynecol Oncol 1997, 67:61-69.
257. Sardi JE, Sanaes CE, Giarolic AA, et al. Neoadjuvant chemotherapy in cervical carcinoma stage IIB: A randomized control trial. Int J Gynecol Cancer 1998, 8:441.
258. Sardi JE Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix-uterus. Gynecol Oncol 1990, 38:486.
259. Scharge JO, Molpus KL, Koelliker D, et al. Stage IB and IIa cervical cancer with negative lymph nodes: The role of adjuvant radiotherapy after radical hysterectomy. Gynecol Oncol 1997, 66:31.
260. Sedlis A, Bundy BN, Rotman MZ, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy. Gynecol Oncol 1999, 73:177.
261. Seibel M, Freeman MG, Graves WL Sexual function after surgical and radiation therapy for cervical carcinoma. South Med J 1982, 75:1195.
262. Sekiba K Radical hysterectomy for cancer of the uterine cervix. Semin Surg Oncol 1985, 1:95.
263. 99mTc-phytate. Gynecol Oncol 2005, 97:588-595.
264. Slater JD, Slater JM, Wahlen S. The potential for proton beam therapy in locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1991, 22:343.
265. Soisson AP, Soper JT, Berchuck A, et al. Radical hysterectomy in obese women. Obstet Gynecol 1992, 80:940.
266. Soisson AP, Soper JT, Clarke-Pearson DL, et al. Adjuvant radiotherapy following radical hysterectomy for patients with stage Ib and IIa cervical cancer. Gynecol Oncol 1990, 37:390.
267. Spirtos NM, Eisenkop SM, Schlaerth JB, Ballon SC Laparoscopic radical hysterectomy (type III) with aortic and pelvic lymphadenectomy in patients with stage I cervical cancer: Surgical morbidity and intermediate follow-up. Am J Obstet Gynecol 2002, 87:340-348.
268. Stallworthy J Radical surgery following radiation treatment for cervical carcinoma. Ann R Coll Surg Engl 1964, 34:161.
269. Steed H, Rosen B, Murphy J, et al. A comparison of laparoscopically-assisted radical vaginal hysterectomy and radical abdominal hysterectomy in the treatment of cervical cancer. Gynecol Oncol 2004, 93:588-589.
270. Steed H, Rosen B, Murphy J, Laframboise S, De Petrillo D, Covens A. A comparison of laparascopic-assisted radical vaginal hysterectomy and radical obdominal hysterectomy in the treatment of cervical cancer. Gynecol Oncol 2004, 93:588.
271. Stehman FB, Bundy BN, DiSaia PJ, et al. Carcinoma of the cervix treated with radiation therapy. I: A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 1991, 67:2776.
272. Stehman FB, Rose PG, Greer BE, et al. Innovations in the treatment of invasive cervical cancer. Cancer 2003, 98(9 Suppl):2052-2063.
273. Surwit EA, Manning MR, Aristizabal SA, et al. Interstitial thermoradiotherapy in recurrent gynecologic malignancies. Gynecol Oncol 1983, 15:95.
274. Syed AMN, Feder BH Technique of afterloading interstitial implant. Radiol Clin 1977, 46:458.
275. Tabata M, Ichinoe K, Sakuragi N, et al. Incidence of ovarian metastasis in patients with cancer of the uterine cervix. Gynecol Oncol 1987, 28:255.
276. Tanguay C, Plante M, Renaud MC, et al. Vaginal radical trachelectomy in the treatment of cervical cancer: The role of frozen section. Int J Gynecol Pathol 2004, 23:170-175.
277. Thomas GM, Dembo AJ Is there a role for adjuvant pelvic radiotherapy after radical hysterectomy in early stage cervical cancer?. Int J Gynecol Cancer 1991, 1:1.
278. Trimbos JB, Maas CP, Deruiter MC, et al. A nerve-sparing radical hysterectomy; Guidelines and feasibility in Western patients. Int J Gynecol Cancer 2001, 11:180-186.
279. Ungar L, Palfalvi L, Hogg R, et al. Abdominal radical trachelectomy: A fertility-preserving option for women with early cervical cancer. Br J Obstet Gynecol 2005, 112:366-369.
280. Weems DH, Mendenhall WM, Bova FJ, et al. Carcinoma of the intact uterine cervix, stages Ib-IIa-b, 6 cm in diameter: Irradiation alone vs preoperative irradiation and surgery. Radiat Oncol Biol Phys 1985, 11:1911.
281. Wharton JT, Jones HW, Day TG, et al. Preirradiation celiotomy and extended field irradiation for invasive carcinoma of the cervix. Obstet Gynecol 1977, 49:333-338.
282. Yabuki Y, Asamoto A, Hoshiba T, et al. Dissection of the cardinal ligament in radical hysterectomy for cervical cancer with emphasis on the lateral ligament. Am J Obstet Gynecol 1991, 164:7.
283. Yessian A, Magistris A, Burger RA, Monk BJ Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy. Gynecol Oncol 2004, 94:61.
284. Zander J, Baltzer J, Lohe KJ, et al. Carcinoma of the cervix: An attempt to individualize treatment: Results of a 20-year cooperative study. Am J Obstet Gynecol 1981, 139:752.
285. Abdulhayoglu G, Rich WM, Reynolds J, et al. Selective radiation therapy in stage Ib uterine cervical carcinoma following radical pelvic surgery. Gynecol Oncol 1980, 10:84.
286. Adcock L, Julian TM, Okagaki T, et al. Carcinoma of the uterine cervix FIGO stage Ib. Gynecol Oncol 1982, 14:199.
287. Alvarez RD, Soong SJ, Kinney WK, et al. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol 1989, 35:130.
288. Baltzer J, Lohe KJ, Kopcke W, et al. Histological criteria for prognosis in patients with operative squamous cell carcinoma of the cervix. Gynecol Oncol 1982, 13:184.
289. Barber HRK, Brunschwig A. Gynecologic cancer complicating pregnancy. Am J Obstet Gynecol 1963, 85:156.
290. Berman ML, Bergen S, Salazar H. Influence of histological features and treatment on the prognosis of patients with cervical cancer metastatic to pelvic lymph nodes. Gynecol Oncol 1990, 39:127.
291. Burghardt E, Baltzer J, Tulusan AH, Haas J. Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer 1992, 70:648.
292. Burke TW, Hoskins WJ, Heller PB, et al. Prognostic factors asso-ciated with radical hysterectomy failure. Gynecol Oncol 1987, 26:153.
293. Chan JK, Loizzi V, Burger RA, et al. Prognostic factors in neuroendocrine small cell cervical carcinoma: A multivariate analysis. Cancer 2003, 97:568.
294. Chen RJ, Lin YH, Chen CA, et al. Influences of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Gynecol Oncol 1999, 73:184.
295. Cooper RA, Wilks DP, Logue JP, et al. High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy. Clin Cancer Res 1998, 4:2795-2800.
296. Davidson B, Goldberg I, Kopolovic J. Angiogenesis in uterine cervical intraepithelial neoplasia and squamous cell carcinoma: An immunohistochemical study. Int J Gynecol Pathol 1997, 16:335.
297. Dawlatly B, Laire O, Cross PA, et al. Prognostic factors in surgically-treated stage IB-IIB squamous cell carcinoma of the cervix with positive lymph nodes. Int J Gynecol Cancer 1998, 8:467.
298. Delgado G, Bundy B, Aino R, et al. Prospective surgery pathological study of disease-free interval in patients with stage IB squamous cell carcinoma cervix. Gynecol Oncol 1990, 38:352.
299. Delgado G Prospective surgical pathological study of disease free interval in patients with stage Ib carcinoma of the cervix: A GOG study. Gynecol Oncol 1990, 38:352.
300. Dellas A, Moch H, Schultheiss E, et al. Angiogenesis in cervical neoplasia; microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathlogical correlations. Gynecol Oncol 1997, 67:27.
301. Dobbs SP, Hewett PW, Johnson IR, et al. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Br J Cancer 1997, 76:1410.
302. Fiorica JV, Roberts WS, Greenberg H, et al. Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy. Gynecol Oncol 1990, 36:343.
303. Francke P, Maruyama J, vanNagell J, et al. Lymphovascular invasion in stage IB cervical carcinoma: Prognostic significance and role of adjuvant radiotherapy. Int J Gynecol Cancer 1996, 6:208.
304. Fuller AF, Elliott N, Kosloff C, et al. Lymph node metastasis from carcinoma of the cervix, stages Ib and IIa: Implications for prognosis and treatment. Gynecol Oncol 1982, 13:165.
305. Gauthier P, Gore I, Shingleton HM, et al. Identification of histopathologic risk groups in stage Ib squamous cell carcinoma of the cervix. Obstet Gynecol 1985, 66:569.
306. Greggi S, Benedett P, Amoroso M, et al. Intraperitoneal tumor spread in locally advanced cervical carcinoma undergoing neoadjuvant chemotherapy. Int J Gynecol Cancer 1998, 8:207.
307. Hagmar B, Christensen JJP, Johansson B, et al. Implications of human papillomavirus type for survival in cervical squamous cell carcinoma. Int J Gynecol Cancer 1995, 5:341.
308. Hopkins MP, Morley GW Squamous cell cancer of the cervix: Prognostic factors related to survival. Int J Gynecol Cancer 1991, 1:173.
309. Hopkins MP, Morley GW Stage IB squamous cell cancer of the cervix: Clinicopathologic feature related to survival. Am J Obstet Gynecol 1991, 164:1520.
310. Inoue T, Morita K. The prognostic significance of number of positive nodes in cervical carcinoma stages Ib, IIa, and IIb. Cancer 1990, 65:1923.
311. Kosary CL FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973-1987 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 1994, 10:31-36.
312. Lanciano RM, Martz K, Montant GS, Hanks GE Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell cancer of the uterine cervix. Cancer 1992, 69:2124.
313. Look KY, Brunetto VL, Clarke-Pearson DL, et al. An analysis of cell type in patients with surgically staged IB carcinoma of the cervix. Gynecol Oncol 1996, 63:304.
314. Lovecchio JL, Averette HE, Donato D, et al. 5-year survival of patients with periaortic nodal metastases in clinical stage Ib and IIa cervical carcinoma. Gynecol Oncol 1989, 34:43.
315. Manetta A, et al. The significance of para-aortic node status in carcinoma of the cervix and endometrium. Gynecol Oncol 1986, 23:284.
316. Mitchell PA, Waggoner S, Rotsnensch J, et al. Cervical cancer in the elderly treated with radiation therapy. Gynecol Oncol 1998, 71:291.
317. Montana GS, Fowler WC, Varia MA, et al. Analysis of results of radiation therapy for stage II carcinoma of the cervix. Cancer 1985, 55:956.
318. Obermair A, Wanner C, Bilgi S, et al. Tumor angiogenesis in stage IB cervical cancer: Correlation of microvessel density with survival. Am J Obstet Gynecol 1998, 178:314-319.
319. Orlandi C, Costa S, Terzano P, et al. Presurgical assessment and therapy of microinvasive carcinoma of the cervix. Gynecol Oncol 1995, 59:255-260.
320. FIGO Annual Report on the Results of Treatment in Gynaecological Cancer. J Epidemiol Biostat 1998, 3:5.
321. Perez CA, Grigsby PW, Nene SM, et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 1992, 69:2796.
322. Peterient DG, Hartenback EM, Thomas GM Para-aortic lymph node evaluation in cervical cancer: The impact of staging upon treatment decisions and outcome. Int J Gynecol Cancer 1998, 8:353.
323. Prempree T, Patanaphan V, Scott R. Radiation management of carcinoma of the cervical stump. Cancer 1979, 43:1262.
324. Rutledge FN, Mitchell MF, Munsell M, et al. Youth as a prognostic factor in carcinoma of the cervix: a matched analysis. Gynecol Oncol 1992, 44:123.
325. Sardi JE, di Paola GR, Giaroli A, et al. Results of a phase II trial with neoadjuvant chemotherapy in carcinoma of the cervix uteri. Gynecol Oncol 1988, 31:256.
326. Stockler M, Russell P, McGaham S, et al. Prognosis and prognostic factors in node-negative cervix cancer. Int J Gynecol Cancer 1996, 6:477.
327. Thomassen LV, Warshaw J, Lawhead RA, Unger ER Invasive cervical cancer in young women. J Reprod Med 1992, 37:901.
328. Tinga DJ, Timmer PR, Bouma J. Prognostic significance of single vs multiple lymph node metastases in cervical carcinoma stage Ib. Gynecol Oncol 1990, 39:175.
329. Ulfelder H, Smith CJ, Costello JB Invasive carcinoma of the cervix during pregnancy. Am J Obstet Gynecol 1967, 98:424.
330. Wang PH, Liu YC, Lai CR, et al. Small cell carcinoma of the cervix: An analysis of clinical and pathological findings. Eur J Gynaecol Oncol 1997, 19:189.
331. Zaino RJ, Ward S, Delgado G, et al. Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study. Cancer 1992, 69:1750.
332. Alberts DS, Garcia D, Mason-Liddil N. Cisplatin in advanced cancer of the cervix: An update. Semin Oncol 1991, 18(1 suppl 3):11.
333. Ampil FL Stage IVa carcinoma of the cervix. Radiat Med 1990, 8:184.
334. Barter JF, Soong SJ, Hatch KD, et al. Diagnosis and treatment of pulmonary metastases from cervical carcinoma. Gynecol Oncol 1990, 38:347.
335. Bassan JS, Glaser MG Bony metastasis in carcinoma of the uterine cervix. Clin Radiol 1982, 33:623.
336. Blythe JG, Cohen MH, Buchsbaum HJ, Latourette HB Bony metastases from carcinoma of cervix. Occurrence diagnosis, and treatment. Cancer 1975, 36:475-484.
337. Burke TW, Hoskins WJ, Heller PB, et al. Clinical patterns of tumor recurrence after radical hysterectomy in stage Ib cervical carcinoma. Obstet Gynecol 1987, 69:382.
338. Christopherson WM, Lundin FE, Mendez WM, Parker JE Cervical cancer control: A study of morbidity and mortality trends over a twenty-one-year period. Cancer 1976, 38:1357-1366.
339. Coleman DL, Gallup DG, Wolcott HD, et al. Patterns of failure of bulky-barrel carcinomas of the cervix. Am J Obstet Gynecol 1992, 166:916.
340. Coleman RL, Keeney ED, Freedman RS, et al. Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy. Gynecol Oncol 1994, 55:29.
341. Delgato G, Goldson AL, Ashayeri E, et al. Intraoperative radiation in the treatment of advanced cervical cancer. Obstet Gynecol 1984, 63:246.
342. El-Minawi MF, Perez-Mesa CM Parametrial needle biopsy follow-up of cervical cancer. Int J Obstet Gynecol 1974, 12:1.
343. Flint A, et al. Confirmation of metastasis by fine needle aspiration biopsy in patients with gynecologic malignancies. Gynecol Oncol 1982, 14:382.
344. Gallousis S Isolated lung metastases from pelvic malignancies. Gynecol Oncol 1979, 7:206.
345. Hartenbach EM, Saltzman AK, Carter JR, et al. Nonsurgical management strategies for the function complications of ileocolonic continent urinary reservoirs. Gynecol Oncol 1995, 59:358.
346. Larson DM, Copeland LJ, Stringer CA, et al. Recurrent cervical carcinoma after radical hysterectomy. Gynecol Oncol 1988, 30:381.
347. Layfield LJ, Heaps JM, Berek JS Fine-needle aspiration cytology accuracy with palpable gynecologic neoplasms. Gynecol Oncol 1991, 40:70.
348. Lifshitz S, Railsback LD, Buchsbaum HJ Intra-arterial pelvic infusion chemotherapy in advanced gynecologic cancer. Obstet Gynecol 1978, 52:476.
349. Lippman SM, Kavanagh JJ, Paredes-Espinoza M, et al. 13-cis-retinoic acid plus interferon α-2a: Highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 1992, 84:241.
350. Long HJ, Bundy BN, Grendys EC, Benda JA, McMeekin DS, Sorosky J, Miller DS, Eaton LA, Fiorica JV Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2005, 23:4626.
351. Look KY, Blessing JA, Muss HB, et al. 5-Fluorouracil and low-dose leucovorin in the treatment of recurrent squamous cell carcinoma of the cervix. Am J Clin Oncol 1992, 15:497.
352. Monk BJ, Huang HQ, Cella D, Long HJ Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2005, 23:4617.
353. Monk BJ, Solh S, Johnson MT, Montz FJ Radical hysterectomy after pelvic irradiation in patients with high-risk cervical cancer or uterine sarcoma: Morbidity and outcome. Eur J Gynecol Oncol 1993, XIV:506.
354. Montana GS, Martz KL, Hanks GE Patterns and sites of failure in cervix cancer treated in the USA in 1978. Int J Radiat Oncol Biol Phys 1991, 20:87.
355. Moore DH, Plessing JA, McQuellon RP, Thaler HT, Cella D, Brenda J, Miller DS, Olt G, King S, Boggess JF, Rocereto TF Phase III study of cisplatin with or without paclitaxel in stave IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2004, 22:3113.
356. Morris M, Blessing JA, Monk BJ, McGehee R, Moore DH Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2004, 22:3340.
357. Murphy WT, Schmitz A. The results of reirradiation of cancer of the cervix. Radiology 1956, 67:378.
358. Mutch DG, Bloss JD Gemcitabine in cervical cancer. Gynecol Oncol 2003, 90:S8.
359. Ng HT, Kan YY, Chao HT, et al. The outcome of the patients with recurrent cervical carcinoma in terms of lymph node metastasis and treatment. Gynecol Oncol 1987, 26:355.
360. Omura GA Current status of chemotherapy for cancer of the cervix. Oncology 1992, 6:27.
361. Park RC, Thigpen JT Chemotherapy in advanced and recurrent cervical cancer. Cancer Suppl 1993, 71:1446.
362. Paunier JP, Delclos L, Fletcher GH Causes, time of death, and sites of failure in squamous-cell carcinoma of the uterine cervix on intact uterus. Radiology 1967, 88:555-562.
363. Peeples WJ, Inalsingh CH, Hazra TA, et al. The occurrence of metastasis outside the abdomen and retroperitoneal space in invasive carcinoma of the cervix. Gynecol Oncol 1976, 4:307.
364. Potter ME, Alvarez RD, Gay GL, et al. Optimal therapy of pelvic recurrence after radical hysterectomy for early stage cervical cancer. Gynecol Oncol 1990, 37:74.
365. Rettenmaier MA, Moran MF, Ramsinghani NF, et al. Treatment of advanced and recurrent squamous carcinoma of the uterine cervix with constant intra-arterial infusion of cisplatin. Cancer 1988, 61:1301.
366. Rubin SC, Hoskins WJ, Lewis JL Radical hysterectomy for recurrent cervical cancer following radiation therapy. Gynecol Oncol 1987, 27:316.
367. Russell AH, Tong DY, Figge DC, et al. Adjuvant postoperative pelvic radiation for carcinoma of the uterine cervix: Pattern of cancer recurrence in patients undergoing elective radiation following radical hysterectomy and pelvic lymphadenectomy. Radiat Oncol Biol Phys 1984, 10:211.
368. Saphner T, Gallion HH, Van Nagell JR, et al. Neurologic complications of cervical cancer: A review of 2261 cases. Cancer 1989, 64:1147.
369. Shield PW, Wright RG, Free K, Daunter B. The accuracy of cervicovaginal cytology in the detection of recurrent cervical carcinoma following radiotherapy. Gynecol Oncol 1991, 41:223.
370. Sommers GM, Grigsby PW, Perez CA, et al. Outcome of recurrent cervical carcinoma following definitive irradiation. Gynecol Oncol 1989, 35:150.
371. Suit HD, Howes AE, Hunter N. Dependence of response of a C3H mammary carcinoma to fractionated irradiation on fractionation number and intertreatment interval. Radiat Res 1977, 72:440-454.
372. Sutton GP, Blessing JA, McGuire WP, et al. Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: A Gynecologic Oncology Group Study. Am J Obstet Gynecol 1993, 168:805.
373. Terada K, Morley GW Radical hysterectomy as surgical salvage therapy for gynecologic malignancy. Obstet Gynecol 1987, 70:913.
374. Tewari KS, Monk BJ The evolution of systemic therapy for palliation of metastatic and relapsing cervical carcinoma. Current Oncology Reports 2005.
375. Thigpen T, Shingleton H, Homesley H, et al. Cis-platinum in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. Cancer 1981, 48:899.
376. Thomas GM Concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after radical surgery. Gynecol Oncol 1987, 27:254.
377. Truelsen F Injury of bones by roentgen treatment of the uterine cervix. Acta Radiol 1942, 23:581.
378. Van Herik M, et al. Late recurrence in carcinoma of the cervix. Am J Obstet Gynecol 1970, 108:1183.
379. Welander CE, Homesley HD, Barrett RJ Combined interferon alpha and doxorubicin in the treatment of advanced cervical cancer. Am J Obstet Gynecol 1991, 165:284.
380. Brin EN, Schiff M, Weiss RM Palliative urinary diversion for pelvic malignancy. J Urol 1975, 113:619-622.
381. Coddington CC, Thomas JR, Hoskins WJ Percutaneous nephrostomy for ureteral obstruction in patients with gynecologic malignancy. Gynecol Oncol 1984, 18:339-348.
382. Höckel M, Baussmann E, Mitze M, Knapstein PG Are pelvic side-wall recurrences of cervical cancer biologically different from central relapses?. Cancer 1994, 74:648-655.
383. Feuer GA, Fruchter R, Seruri E, et al. Selection for percutaneous nephrostomy in gynecologic cancer patients. Gynecol Oncol 1991, 42:60.
384. Ijoz T, Eifel PJ, Burke T, et al. Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma. Gynecol Oncol 1998, 70:241.
385. Orr JW, Ball GC, Soong SJ, et al. Surgical treatment of women found to have invasive cervix cancer at the time of total hysterectomy. Obstet Gynecol 1986, 68:353.
386. Samlal RAK, Van der Velden J, Van E, Erden T, et al. Recurrent cervical carcinoma after radical hysterectomy: An analysis of clinical aspect and prognosis. Int J Gynecol Cancer 1998, 8:78.
387. Averette HE, Lichtinger M, Sevin BU, et al. Pelvic exenteration: A 15-year experience in a general metropolitan hospital. Am J Obstet Gynecol 1984, 150:179.
388. Barber HRK Relative prognostic significance of preoperative and operative findings in pelvic exenteration. Surg Clin North Am 1969, 49:431.
389. Barber HRK, Jones W. Lymphadenectomy in pelvic exenteration for recurrent cervix cancer. JAMA 1971, 215:1949.
390. Behtash N, Mousavi A, Tehranian A, Khanafshar N, Hanjani P. Embryonal rhabdomyosarcoma of the uterine cervix: case report and review of the literature. Gynecol Oncol 2003, 91:452.
391. Berman ML, Lagasse LD, Watring WG, et al. Enteroperineal fistulae following pelvic exenteration: A 10-point program of management. Gynecol Oncol 1976, 4:368.
392. Bricker EM Bladder substitution after pelvic evisceration. Surg Clin North Am 1950, 30:1511.
393. Bricker EM, Butcher HR, McAfee A. Results of pelvic exenteration. Arch Surg 1956, 73:661.
394. Brunschwig A What are the indications and results of pelvic exenteration?. JAMA 1965, 194:274.
395. Brunschwig A, Pierce VK Necropsy findings in patients with carcinoma of the cervix: Implications for treatment. Am J Obstet Gynecol 1948, 56:1134.
396. Carlson JW, Soisson AP, Fowler JM, et al. Rectus abdominis myocutaneous flap for primary vaginal reconstruction. Gynecol Oncol 1993, 51:323.
397. Creasman WT, Rutledge F Is positive pelvic lymphadenectomy a contraindication to radical surgery in recurrent cervical carcinoma?. Gynecol Oncol 1974, 2:282.
398. Gruessner SE, Omwandho CO, Dreyer T, Blutters-Sawatzki R, Reiter A, Tinneburg HR, Bohle RM Management of stage I cervical sarcoma botryoides in childhood and adolescence. Eur J Pediatr 2004, 163:452.
399. Hancock KC, Copeland LJ, Gershenson DM, et al. Urinary conduits in gynecologic oncology. Obstet Gynecol 1986, 67:680.
400. Hatch KD, Shingleton HM, Potter ME, et al. Low rectal resection and anastomosis at the time of pelvic exenteration. Gynecol Oncol 1988, 32:262.
401. Hoffman MS, Lynch CM, Gleeson NC, et al. Colorectal anastomosis on a gynecologic oncology service. Gynecol Oncol 1994, 55:60.
402. Hökel M, Schlenger K, Hamm H, et al. Five year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall. Cancer 1996, 77:1918.
403. Irvin W, Presley A, Anderson W, Taylor P, Rice L. Leiomyosarcoma of the cervix. Gynecol Oncol 2003, 91:636.
404. Ketcham AS, Deckers PJ, Sugarbaker EV, et al. Pelvic exenteration for carcinoma of the uterine cervix: A 15-year experience. Cancer 1970, 26:513.
405. Lawhead RA Pelvic exenteration for recurrent or persistent gynecologic malignancies: A 10-year review of the Memorial Sloan-Kettering Cancer Center Experience (1972-1981). Gynecol Oncol 1989, 33:279.
406. Lee JW, Kim YT, Min YH, Kim SH, Park KH, Lim BJ, Yang WI Granulocytic sarcoma of the uterine cervix. Int J Gynecol Cancer 2004, 14:553.
407. Lichtinger M, Averette H, Girtanner R, et al. Small bowel complications after supravesical urinary diversion in pelvic exenteration. Gynecol Oncol 1986, 24:137.
408. Magrina JF Types of pelvic exenterations: A reappraisal. Gynecol Oncol 1990, 37:363.
409. Morley GW, Lindenauer SM Pelvic exenteration therapy for gynecologic malignancies: An analysis of 70 cases. Cancer 1976, 38:581.
410. Morley GW, Lindenauer SM, Young D. Vaginal reconstruction following pelvic exenteration. Am J Obstet Gynecol 1973, 116:996.
411. Ng C, Amis S Radiology of continent urinary diversion. Contemp Urorad 1991, 29:557.
412. Orr JW, Shingleton HM, Hatch KD, et al. Urinary diversion in patients undergoing pelvic exenteration. Am J Obstet Gynecol 1982, 142:883.
413. Park TK, Choi DH, Kim SN, et al. Role of induction chemotherapy in invasive cervical cancer. Gynecol Oncol 1991, 41:1007.
414. Penalver M, Averette H, Sevin BU, et al. Gastrointestinal surgery in gynecologic oncology: Evaluation of surgical techniques. Gynecol Oncol 1987, 28:74.
415. Roberts WS, Cavanagh D, Bryson SC, et al. Major morbidity after pelvic exenteration: A seven year experience. Obstet Gynecol 1987, 69:617.
416. Rutledge FN, Burns BC Pelvic exenteration. Am J Obstet Gynecol 1965, 91:692.
417. Rutledge FN, McGuffee VB Pelvic exenteration: Prognostic significance of regional lymph node metastasis. Gynecol Oncol 1987, 26:374.
418. Rutledge FN, Smith JP, Wharton JT, et al. Pelvic exenteration: Analysis of 296 patients. Am J Obstet Gynecol 1977, 129:881.
419. Sharma S, Odunsi K, Driscoll D, Lele S. Pelvic exenterations for gynecological malignancies: Twenty-year experience at Roswell Park Cancer Institute. Int J Gynecol Cancer 2005, 15:475.
420. Shingleton HM, Soong SJ, Gelder MS, et al. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 1989, 73:1027.
421. Snijders-Keilholz A, Ewing P, Seynaeve C, Burger CW Primitive neuroectodermal tumor of the cervix uteri: A case report Changing concepts in therapy. Gynecol Oncol 2005, 98:516.
422. Soper JT, Berchuck A, Creasman WT, et al. Pelvic exenteration: Factors associated with major surgical morbidity. Gynecol Oncol 1989, 35:93.
423. Stanhope CR, Symmonds RE, Lee RA, et al. Urinary diversion with use of ileal and sigmoid conduit. Am J Obstet Gynecol 1986, 155:288.
424. Swan RW, Rutledge FN Urinary conduit in pelvic cancer patients: a report of 16 years' experience. Am J Obstet Gynecol 1974, 119:6.
425. Symmonds RE, Pratt JH, Webb MJ Exenteration operations: Experience with 198 patients. Am J Obstet Gynecol 1975, 121:907.
426. Walton LA The stress of radical pelvic surgery: a review. Gynecol Oncol 1979, 7:25.
427. Wheelers CR Incidence of fecal incontinence after coloproctostomy below five centimeters in the rectum. Gynecol Oncol 1987, 27:373.
428. Wheelers CR Recent advances in surgical reconstrution of the gynecologic cancer patient. Curr Opin Obstet Gynecol 1992, 4:91.
429. Abdul-Karim RW, et al. Sarcoma of the uterine cervix: Clinicopathologic findings in three cases. Gynecol Oncol 1987, 26:103.
430. Akine Y, et al. Carcinoma of the uterine cervix treated by irradiation alone: Result of treatment at the National Cancer Center, Tokyo. Acta Oncol 1989, 29:747.
431. Brand E, Berek JS, Nieberg RK, et al. Rhabdomyosarcoma of the uterine cervix: Sarcoma botryoides. Cancer 1987, 60:1552.
432. Kristiansen SB, Anderson R, Cohen DM Case report: Primary malignant melanoma of the cervix and review of the literature. Gynecol Oncol 1992, 47:398.
433. Montag RW, D'Abaing G, Schlaerth JB Embryonal rhabdomyosarcoma of the uterine corpus and cervix. Gynecol Oncol 1986, 25:171.
434. Mordel N, Mor-Yosef S, Ben-Baruch N, et al. Malignant melanoma of the uterine cervix: Case report and review of the literature. Gynecol Oncol 1989, 32:375.
435. Muntz GH, et al. Stage IE primary malignant lymphomas of the uterine cervix. Cancer 1991, 68:2023.
436. Perren T, et al. Case report: Lymphomas of the cervix and upper vagina: A report of five cases and a review of the literature. Gynecol Oncol 1992, 44:87.
437. Rotmensch J, Rosensheim NB, Woodruff JD Cervical sarcoma: A review. Obstet Gynecol Surg 1983, 38:456.